We are live on ! Find out more
QSI icon

Quantum-Si Incorporated

0.8031 USD
+0.0125
1.58%
At close Updated Aug 27, 4:00 PM EDT
Pre-market
After hours
0.8000
-0.0031
0.39%
1 day
1.58%
5 days
2.33%
1 month
2.51%
3 months
-28.93%
6 months
-16.03%
Year to date
-30.77%
1 year
-30.77%
5 years
-91.7%
10 years
-91.87%
 

About: Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Employees: 145

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 88.9%
Negative 11.1%
Neutral
GlobeNewsWire
9 days ago
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
BRANFORD, Conn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced that it will be participating in the H.C.
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Neutral
Seeking Alpha
13 days ago
Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript
Neutral
MarketBeat
13 days ago
Quantum-Si Q2 Earnings Call Highlights
Quantum-Si NASDAQ: QSI said it has moved the planned launch of its Proteus protein sequencing platform to the second quarter of 2027 from the end of 2026, citing the need for an additional integrated instrument design cycle before production. The company also announced a targeted workforce reduction of about 20% as it seeks to lower cash burn and fund the revised development timeline.
Quantum-Si Q2 Earnings Call Highlights
Negative
Zacks Investment Research
14 days ago
Quantum-Si Incorporated (QSI) Reports Q2 Loss, Tops Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.16 per share a year ago.
Quantum-Si Incorporated (QSI) Reports Q2 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
14 days ago
Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update
Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new market opportunities for protein sequencing BRANFORD, Conn., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced financial results for the second quarter ended June 30, 2026.
Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update
Neutral
GlobeNewsWire
1 month ago
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
BRANFORD, Conn., July 27, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the second quarter 2026 on Thursday, August 13, 2026.
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
Neutral
Business Wire
2 months ago
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Business Wire
2 months ago
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™.
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
Neutral
Business Wire
2 months ago
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Expansion of the Proteus™ Roadshow.
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
Neutral
Seeking Alpha
3 months ago
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Price charts implemented using Lightweight Charts™